Cingulate (CINGW) Retained Earnings (2021 - 2026)
Cingulate's (CINGW) quarterly Retained Earnings came in at $171.0 million in Q2 2026, up 26.79% quarter-over-quarter from $134.9 million in Q4 2025.
Analysis
Cingulate (CINGW) Retained Earnings (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Retained Earnings for 6 consecutive years, with $171.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings changed N/A year-over-year to $171.0 million; the trailing twelve-month figure through Jun 2026 stood at $171.0 million (changed N/A YoY), and the FY2025 full-year result was $134.9 million, up 14.91% from the prior year.
- Retained Earnings improved to $171.0 million in Q2 2026 per CINGW's latest filing, from $134.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $171.0 million in Q2 2026 and bottomed at -$92.9 million in Q4 2023.
- Historically, Retained Earnings has averaged $68.3 million across 5 years, with a median of $86.3 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings tumbled 226.82% in 2023, then soared 233.0% in 2024.
- Over 5 years, Retained Earnings stood at $73.3 million in 2022, then sank by 226.82% to -$92.9 million in 2023, then soared by 226.29% to $117.4 million in 2024, then grew by 14.91% to $134.9 million in 2025, then grew by 26.79% to $171.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $171.0 million, $134.9 million, and $129.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | -4.00 Bn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 171.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.02 Mn |
| Dec 31, 2025 | 134.88 Mn |
| Sep 30, 2025 | 129.58 Mn |
| Mar 31, 2025 | 118.22 Mn |
| Dec 31, 2024 | 117.38 Mn |
| Sep 30, 2024 | 114.39 Mn |
| Jun 30, 2024 | 102.21 Mn |
| Mar 31, 2024 | 99.13 Mn |
| Dec 31, 2023 | -92.94 Mn |
| Sep 30, 2023 | -86.01 Mn |
| Jun 30, 2023 | -80.03 Mn |
| Mar 31, 2023 | 73.49 Mn |
| Dec 31, 2022 | 73.29 Mn |
| Sep 30, 2022 | 73.17 Mn |
| Jun 30, 2022 | 72.96 Mn |
| Mar 31, 2022 | 72.76 Mn |
| Dec 31, 2021 | 72.57 Mn |